[{"id":"idea-til-guided-deescalation","kind":"idea","name":"TIL-based omission of chemotherapy in stage I TNBC","route":"/ideas/idea-til-guided-deescalation/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/ideas.ts","type":"changed","fields":[{"field":"tldr","before":"\"Small triple-negative tumours packed with immune cells almost never come back. Skip chemotherapy for those patients.\"","after":"\"Small triple-negative tumours packed with immune cells almost never come back. The idea is to skip chemotherapy for those patients.\""},{"field":"test","before":"\"Single-arm prospective trial with a non-inferiority boundary (e.g., 5-year iDFS >90%), central AI-assisted TIL scoring, and ctDNA surveillance as a safety net.\"","after":"\"Run a single-arm prospective trial with a non-inferiority boundary (e.g., 5-year iDFS >90%), central AI-assisted TIL scoring, and ctDNA surveillance as a safety net.\""}]},{"id":"idea-til-guided-deescalation","kind":"idea","name":"TIL-based omission of chemotherapy in stage I TNBC","route":"/ideas/idea-til-guided-deescalation/","commit":"815a2a8bae","date":"2026-09-05","author":"Jude Gomila","message":"OnCo: open map of oncology — corpus (642 objects, 14 kinds), graph, static site, API, TNBC spike","file":"src/data/ideas.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"maturity"},{"field":"tldr"},{"field":"summary"},{"field":"hypothesis"},{"field":"rationale"},{"field":"test"},{"field":"technologies"},{"field":"terms"},{"field":"cancers"}]}]